Mediterranean Journal of Hematology and Infectious Diseases最新文献

{"title":"Correlation of Transient Elastography with Liver Iron Concentration and Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia Major from Oman.","authors":"H Khan,&nbsp;V Panjwani,&nbsp;S Al Rahbi,&nbsp;A Eltigani,&nbsp;R N Qureshi,&nbsp;K Unissa,&nbsp;N Sehar,&nbsp;A Mittal,&nbsp;A V Pathare","doi":"10.4084/MJHID.2023.048","DOIUrl":"https://doi.org/10.4084/MJHID.2023.048","url":null,"abstract":"<p><strong>Aims: </strong>In a longitudinal study, we aimed to assess the correlation between ultrasound transient elastography (TE), serum ferritin (SF), liver iron content (LIC) by magnetic resonance imaging (MRI) T2* along with the fibrosis-4 (FIB-4) score as a screening tool to detect significant liver fibrosis among chronically transfusion-dependent beta-thalassemia (TDT) patients.</p><p><strong>Methods: </strong>The study was conducted at a tertiary health center treating TDT patients. Transient elastography was performed within 3 months of Liver MRI T2* examinations at the radiology department over a median of one-year duration. T-test for independent data or Mann-Whitney U test was used to analyze group differences. Spearman correlation with linear regression analysis was used to evaluate the correlation between TE liver stiffness measurements, Liver MRI T2* values, and SF levels.</p><p><strong>Results: </strong>In this study on 91 patients, the median age (IQR) of the subjects was 33 (9) years, and the median (IQR) body mass index was 23.8 (6.1) kg/m². Median (IQR) TE by fibroscan, MRI T2*(3T), Liver iron concentration (LIC) by MRI Liver T2*, and SF levels were 6.38 (2.6) kPa, 32.4 (18) milliseconds, 7(9) g/dry wt., and 1881 (2969) ng/mL, respectively. TE measurements correlated with LIC g/dry wt. (rS =0.39, p=0.0001) and with SF level (rS =0.43, P=0.001) but not with MRI T2* values (rS =-0.24; P=0.98).</p><p><strong>Conclusion: </strong>In TDT patients, liver stiffness measured as TE decreased significantly with improved iron overload measured as LIC by MRI and SF levels. However, there was no correlation of TE with the fibrosis-4 (FIB-4) score.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/df/4a/mjhid-15-1-e2023048.PMC10497312.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10625944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Novel <i>RUNX1</i> Variation in B-cell Acute Lymphoblastic Leukemia.","authors":"Egzona Qipa,&nbsp;Muradiye Acar,&nbsp;Sureyya Bozkurt,&nbsp;Murat Buyukdogan,&nbsp;Hazal B Sonmez,&nbsp;Muge Sayitoglu,&nbsp;Yucel Erbilgin,&nbsp;Zeynep Karakaş,&nbsp;Veysel S Hançer","doi":"10.4084/MJHID.2023.036","DOIUrl":"https://doi.org/10.4084/MJHID.2023.036","url":null,"abstract":"<p><p>Acute lymphoblastic leukemia (ALL) is a malignant disease of hematopoietic stem cells. B cell ALL (B-ALL) is characterized by highly proliferative and poorly differentiated progenitor B cells in the bone marrow. Chromosomal rearrangements, aberrant cell signaling, and mutations lead to dysregulated cell cycle and clonal proliferation of abnormal B cell progenitors. In this study, we aimed to examine hot spot genetic variations in the <i>RUNX1</i>, <i>IDH2</i>, and <i>IL2RA</i> genes in a group of (n=52) pediatric B-ALL. Sanger sequencing results revealed a rare <i>RUNX1</i> variant p.Leu148Gln in one B-ALL patient with disease recurrence. Additionally, common intronic variations rs12358961 and rs11256369 of IL2RA were determined in two patients. None of the patients had the IDH2 variant. <i>RUNX1, IDH2</i>, and <i>IL2RA</i> variations were rare events in ALL. This study detected a novel pathogenic RUNX1 variation in a patient with a poor prognosis. Examining prognostically important genetic anomalies of childhood lymphoblastic leukemia patients and the signaling pathway components will pilot more accurate prognosis estimations.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/06/9f/mjhid-15-1-e2023036.PMC10332349.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9817920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Immune Thrombocytopenia Onset and Relapse During the COVID-19 Pandemic. A Monocenter Study.","authors":"Giuseppe Auteri,&nbsp;Simona Paglia,&nbsp;Camilla Mazzoni,&nbsp;Mattia Biondo,&nbsp;Marta Venturi,&nbsp;Andrea Davide Romagnoli,&nbsp;Daniela Bartoletti,&nbsp;Michele Cavo,&nbsp;Nicola Vianelli,&nbsp;Francesca Palandri","doi":"10.4084/MJHID.2023.029","DOIUrl":"https://doi.org/10.4084/MJHID.2023.029","url":null,"abstract":"<p><strong>Background and objectives: </strong>Several infections and vaccinations can provoke immune thrombocytopenia (ITP) onset or relapse. Information on ITP epidemiology and management during the Covid-19 pandemic is scarce. In a large monocenter ITP cohort, we assessed the incidence and risk factors for: 1) ITP onset/relapse after Covid19 vaccination/infection; 2) Covid19 infection.</p><p><strong>Methods: </strong>Information on the date/type of anti-Covid-19 vaccine, platelet count before and within 30 days from the vaccine, and date/grade of Covid-19 was collected via phone call or during hematological visits. ITP relapse was defined as a drop in PLT count within 30 days from vaccination, compared to PLT count before vaccination that required a rescue therapy OR a dose increase of an ongoing therapy OR a PLT count <30 ×10⁹/L with ≥20% decrease from baseline.</p><p><strong>Results: </strong>Between February 2020 and January 2022, 60 new ITP diagnoses were observed (30% related to Covid-19 infection or vaccination). Younger and older ages were associated with a higher probability of ITP related to Covid19 infection (p=0.02) and vaccination (p=0.04), respectively. Compared to Covid-19-unrelated ITP, Infection- and vaccine-related ITP had lower response rates (p=0.03) and required more prolonged therapy (p=0.04), respectively. Among the 382 patients with known ITP at the pandemic start, 18.1% relapsed; relapse was attributed to Covid-19 infection/vaccine in 52.2%. The risk of relapse was higher in patients with active disease (p<0.001) and previous vaccine-related relapse (p=0.006). Overall, 18.3% of ITP patients acquired Covid19 (severe in 9.9%); risk was higher in unvaccinated patients (p<0.001).</p><p><strong>Conclusions: </strong>All ITP patients should receive ≥1 vaccine dose and laboratory follow-up after vaccination, with a case-by-case evaluation of completion of the vaccine program if vaccine-related ITP onset/relapse and with tempest initiation of antiviral therapy in unvaccinated patients.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ce/5f/mjhid-15-1-e2023029.PMC10171210.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9469378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Evolving Role of Haematology Nursing Practice: A Cross-Sectional Survey.","authors":"Sarah Liptrott,&nbsp;Mairéad NíChonghaile,&nbsp;Liz O'Connell,&nbsp;Erik Aerts","doi":"10.4084/MJHID.2023.033","DOIUrl":"https://doi.org/10.4084/MJHID.2023.033","url":null,"abstract":"<p><strong>Background and objectives: </strong>The scope of haematology nursing practice is dynamic and must respond to advances in treatment, patients' needs and service requirements. Little is known, however, about the different roles of haematology nurses across the European setting. The purpose of this study was to identify the professional practices of haematology nurses.</p><p><strong>Method: </strong>A cross-sectional online survey design was used to investigate practice elements undertaken by haematology nurses. Frequencies and descriptive statistics were calculated for demographic variables and chi-square tests to examine relationships between practice elements, nursing role and country.</p><p><strong>Results: </strong>Data is reported from 233 nurses across 19 countries, working as Staff Nurses (52.4%), senior nurses (12.9%) and Advanced Practice Nurses (APNs) (34.8%). Most frequently reported activities included medication administration - oral/ intravenous (90.0%), monoclonal antibodies (83.8%), chemotherapy (80.6%), and blood components (81.4%). APNs were more commonly involved in nurse-led clinics and prescribing activities (p < .001, p = .001, respectively); however, other nursing groups also reported performing extended practice activities. Patient and carer education was a significant part of all nurses' roles; however, senior nurses and APNs were more often involved with the multidisciplinary team (p < .001) and managerial responsibilities (p < .001). Nurses' involvement in research was limited (36.3%) and frequently reported as an out-of-work hours activity.</p><p><strong>Conclusions: </strong>This study describes haematology nursing care activities performed in various contexts and within different nursing roles. It provides further evidence of nursing activity and may contribute to a core skills framework for haematology nurses.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/13/8d/mjhid-15-1-e2023033.PMC10171204.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9469380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Carboxyhemoglobin Levels in Preterm Neonatal Late-Onset Sepsis: to Predict or not to Predict.","authors":"Gonca Vardar,&nbsp;Eren Ozek","doi":"10.4084/MJHID.2023.017","DOIUrl":"https://doi.org/10.4084/MJHID.2023.017","url":null,"abstract":"<p><strong>Background: </strong>In this study, we aimed to evaluate carboxyhemoglobin (COHb) levels in diagnosing late-onset sepsis (LOS) in preterm neonates.</p><p><strong>Methods: </strong>The records of culture-positive LOS in preterm neonates hospitalized in NICU from January 2017 to July 2022 were reviewed. COHb levels, C-reactive protein, procalcitonin, and neutrophil to lymphocyte ratio of septic preterm infants were compared to controls. In addition, serial COHb levels measured within six hours before or 24h after blood culture sampling, three to seven days prior, and three to five days after starting antimicrobial therapy were retrieved from patient records.</p><p><strong>Results: </strong>The study included 77 blood-culture-positive preterm infants and 77 non-septic controls. During the LOS episode, the COHb values were found to be significantly increased (median: 1.8, IQR: 1.4-2.5) when compared to the control group (median: 1.2, IQR: 0.8-1.6) (p < 0.001). ROC analysis yielded an AUC of 0.714 for COHb (95% CI: 0.631-0.796, p<0.001). At an optimal cut-off of >1.5%, the test's sensitivity was 64.94%, the specificity was 72.73%, the positive predictive value was 70.42%, and the negative predictive value was 67.47%. LOS led to a dramatic rise followed by a decrease after the initiation of the antimicrobial therapy [1.8 (1.4-2.5)] vs. [1.45 (0.2-4)] p<0.001.</p><p><strong>Conclusion: </strong>COHb levels increased at the beginning of LOS, decreasing in response to antibiotics. When used in conjunction with other sepsis biomarkers, the variation of COHb can be important in evaluating late-onset sepsis episodes in preterm infants.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9a/46/mjhid-15-1-e2023017.PMC10000836.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9099893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Therapy-related Myeloid Neoplasms: Considerations for Patients' Clinical Evaluation.","authors":"Raffaele Palmieri,&nbsp;Giovangiacinto Paterno,&nbsp;Flavia Mallegni,&nbsp;Federica Frenza,&nbsp;Ilenia De Bernardis,&nbsp;Federico Moretti,&nbsp;Elisa Meddi,&nbsp;Maria Ilaria Del Principe,&nbsp;Luca Maurillo,&nbsp;Adriano Venditti,&nbsp;Francesco Buccisano","doi":"10.4084/MJHID.2023.051","DOIUrl":"https://doi.org/10.4084/MJHID.2023.051","url":null,"abstract":"<p><p>Therapy-related myeloid neoplasms (t-MNs) encompass a specific sub-group of myeloid malignancies arising after exposure to radio/cytotoxic agents for the treatment of unrelated diseases. Such malignancies present unique features, including advanced age, high comorbidities burden, and unfavorable genetic profiles. All these features justify the need for a specific diagnostic work-up and dedicated treatment algorithms. However, as new classification systems recognize the unique clinical characteristics exhibited by t-MN patients, how to assess fitness status in this clinical setting is largely unexplored. Optimizing fitness assessment would be crucial in the management of t-MN patients, considering that factors usually contributing to a worse or better outcome (like age, comorbidities, and treatment history) are patient-specific. In the absence of specific tools for fitness assessment in this peculiar category of AML, the aim of this review is to describe all those factors related to patient, treatment, and disease that allow planning treatments with an optimal risk/benefit ratio.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d4/b4/mjhid-15-1-e2023051.PMC10497317.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10252200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hemoglobin H Disease and Growth: A Comparative Study of DHbH and NDHbH Patients.","authors":"Issanun Hunnuan,&nbsp;Kleebsabai Sanpkit,&nbsp;Ornsuda Lertbannaphong,&nbsp;Jassada Buaboonnam","doi":"10.4084/MJHID.2023.045","DOIUrl":"https://doi.org/10.4084/MJHID.2023.045","url":null,"abstract":"<p><strong>Background: </strong>Hemoglobin H disease <i>(</i>HbH<i>)</i>, a hemoglobinopathy resulting from abnormal alpha globin genes, is classified into two categories: deletional HbH <i>(</i>DHbH<i>)</i> and non-deletional HbH <i>(</i>NDHbH<i>)</i>. The alpha-mutation genotypes exhibit a range of clinical anemias, which differentially impact patient growth.</p><p><strong>Objectives: </strong>This retrospective study assessed the growth of HbH patients at Siriraj Hospital, Mahidol University.</p><p><strong>Methods: </strong>Patients diagnosed with HbH between January 2005 and April 2021 were analyzed using growth standard scores of the Thai Society for Pediatric Endocrinology (2022 version) and BMI-for-age Z scores of the World Health Organization. Growth failure was defined as a patient's height for age exceeding two standard deviations below the mean.</p><p><strong>Results: </strong>Of the 145 HbH patients, 75 <i>(</i>51.7<i>%)</i> had NDHbH, with --^SEA<i>/</i>α^CSα being the most common genotype <i>(</i>70 patients; 93.3<i>%)</i>. The mean baseline hemoglobin level was significantly lower in NDHbH patients than in DHbH patients (8.16 ± 0.93 g<i>/</i>dL vs. 9.51 ± 0.68 g<i>/</i>dL; <i>P</i> < 0.001<i>)</i>. Splenomegaly and growth failure prevalences were higher in NDHbH patients (37.3<i>%</i> vs. 0%, with <i>P</i> < 0.001, and 22.7% vs. 8.6%, with <i>P</i> = 0.020, respectively). Multivariable analysis revealed splenomegaly > 3 cm was associated with growth failure (OR = 4.28; 95% CI, 1.19-15.39; <i>P</i> = 0.026).</p><p><strong>Conclusions: </strong>NDHbH patients exhibited lower hemoglobin levels and more pronounced splenomegaly than DHbH patients. Growth failure can occur in both HbH types but appears more prevalent in NDHbH. Close monitoring of growth velocity is essential, and early treatment interventions may be required to prevent growth failure.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f1/4c/mjhid-15-1-e2023045.PMC10497309.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10252202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adverse Pregnancy Outcomes in Sickle Cell Trait: a Prospective Cohort Study Evaluating Clinical and Haematological Parameters in Postpartum Mothers and Newborns.","authors":"E H Ali,&nbsp;S Alkindi,&nbsp;A O Mohamed,&nbsp;K E Awadalla,&nbsp;O Abdlgadir,&nbsp;G Adam,&nbsp;M Magdi,&nbsp;A K Ibrahim,&nbsp;K Ghebremeskel","doi":"10.4084/MJHID.2023.002","DOIUrl":"10.4084/MJHID.2023.002","url":null,"abstract":"<p><strong>Background: </strong>Sickle cell trait (SCT) is a congenital condition caused by the inheritance of a single allele of the abnormal haemoglobin beta gene, HbS. Carriers of SCT are generally asymptomatic, and they do not manifest the clinical and haematological abnormalities of sickle cell anaemia (SCA). However, there is evidence that they display some symptoms in stressful situations. Pregnancy is a stressful physiological event, and it is not clear if SCT adversely affects pregnancy outcomes, particularly in those from developing countries where people regularly suffer from nutritional insufficiency.</p><p><strong>Objective: </strong>This study aims to investigate pregnancy outcomes in Sudanese women with SCT. <i>Subjects and methods:</i> Pregnant women with (HbAS, n=34) and without (HbAA, n=60) SCT were recruited during their first trimester at El Obeid Hospital, Kordofan, Western Sudan. Following appropriate ethical approval and informed consent from the participants, detailed anthropometric, clinical, haematological, obstetric, and birth outcome data were registered. In addition, blood samples were collected at enrolment and at delivery.</p><p><strong>Results: </strong>At enrolment in the first trimester, the SCT group did not manifest SCA symptoms, and there was no difference in the haematological parameters between the SCT and control groups. However, at delivery, the women with SCT, compared with the control group, had lower levels of hemoglobin (Hb, p=0.000), packed cell volume (PCV, p=0.000), mean corpuscular haemoglobin (MCH, p=0.002) and neutrophil counts (p=0.045) and higher mean corpuscular volume (MCV, p=0.000) and platelet counts (p=0.000). Similarly, at delivery, the babies of SCT women had lower birth weight (p=0.000), lower Hb (p=0.045), PCV (p=0.000), MCH (p=0.000), and higher neutrophil (p=0.004) and platelet counts (p=0.000) than the babies of the healthy control group. Additionally, there were more miscarriages, stillbirths, and admissions to the Special Care Baby Unit (SCBU) in the SCT group.</p><p><strong>Conclusions: </strong>The study revealed that SCT is associated with adverse pregnancy outcomes, including maternal and neonatal anaemia, low birth weight, and increased risk of stillbirth, miscarriage, and admission to SCBU. Therefore, pregnant women with SCT should be given appropriate pre-conceptual advice and multidisciplinary antenatal and postnatal care.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/39/15/mjhid-15-1-e2023002.PMC9833303.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10624872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bacteraemia Among Patients with Sickle Cell Disease in Nigeria: Association with Spleen Size and Function.","authors":"Adama I Ladu,&nbsp;Mairo U Kadaura,&nbsp;Mohammed Dauda,&nbsp;Abubakar Sadiq Baba,&nbsp;Caroline Jeffery,&nbsp;Abubakar Farate,&nbsp;Adekunle Adekile,&nbsp;Imelda Bates,&nbsp;Russell Dacombe","doi":"10.4084/MJHID.2023.054","DOIUrl":"https://doi.org/10.4084/MJHID.2023.054","url":null,"abstract":"","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/a9/mjhid-15-1-e2023054.PMC10497316.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10252194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Justification of Universal Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia.","authors":"Phakatip Sinlapamongkolkul,&nbsp;Pacharapan Surapolchai,&nbsp;Vip Viprakasit","doi":"10.4084/MJHID.2023.056","DOIUrl":"https://doi.org/10.4084/MJHID.2023.056","url":null,"abstract":"<p><strong>Introduction: </strong>Many clinicians hesitate to adopt a universal infant iron supplementation program due to the risk of increased iron absorption for those with thalassemia. We aimed to determine thalassemia prevalence in 6- to 12-month-old infants, along with the iron status of those with and without thalassemia.</p><p><strong>Methods: </strong>We performed a cross-sectional descriptive study of infants attending the Well Baby Clinic at Thammasat University Hospital for routine checkups. Complete blood count, hemoglobin electrophoresis, iron parameters, and molecular genetics for common α- and β-thalassemia were evaluated.</p><p><strong>Results: </strong>Overall, 97 of 206 (47%) participants had thalassemia minor, the majority having Hb E traits. None had thalassemia intermedia or major. Familial history of anemia or thalassemia presented an increased risk of detecting thalassemia minor in offspring (OR 5.18; 95% CI 2.60-10.33, <i>p</i>=0.001). There were no statistical differences in transferrin saturation, serum ferritin and hepcidin between iron-replete infants with thalassemia minor and those without. However, one-third of infants with thalassemia minor (31/97) also had iron deficiency anemia (IDA), with a similar risk of having iron deficiency to infants without thalassemia. There was no hepcidin suppression in our infants with thalassemia minor as compared to controls.</p><p><strong>Conclusions: </strong>Both thalassemia and IDA are endemic to Southeast Asia. Infants with thalassemia minor, particularly with Hb E and α-thalassemia traits, are at risk of IDA. Our short-term universal iron supplementation program for 6- to 12-month-old infants does not appear to increase the risk of those with thalassemia minor developing iron overload in the future.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/eb/3f/mjhid-15-1-e2023056.PMC10497306.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10260067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}